Notatum-Quentans Nasal 4X (BioResource Inc.)


Welcome to the PulseAid listing for the Notatum-Quentans Nasal 4X drug offered from BioResource Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: BioResource Inc.
NON-PROPRIETARY NAME: Penicillium Chrysogenum Var. Chrysogenum and Penicillium Glabrum
SUBSTANCE NAME: PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM GLABRUM
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: NASAL
DOSAGE FORM: SPRAY
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2016-01-01
END MARKETING DATE: 0000-00-00


Notatum-Quentans Nasal 4X HUMAN OTC DRUG Details:

Item DescriptionNotatum-Quentans Nasal 4X from BioResource Inc.
LABELER NAME: BioResource Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 4; 4([hp_X]/10mL; [hp_X]/10mL)
START MARKETING DATE: 2016-01-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54256-046_6998060c-d0a7-49b7-917a-7456e6f2637c
PRODUCT NDC: 54256-046
APPLICATION NUMBER:

Other PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PENICILLIUM GLABRUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
BioResource Inc.Notatum-Quentans Nasal 4X
sanPharma GmbHNotaQuenSAN
Sanum-Kehlbeck GmbH & Co. KGPleo Nota-Quent
Syntrion GmbHSyInfect
USPharmaCoNotatum-Quentans